MOOSTIN 40MG TABLET
₹777.6*
MRP ₹864
10% off
₹734*
MRP ₹864
15% CB
₹130 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
MOOSTIN 40MG TABLET is an anti-cancer medicine used in the treatment of brain tumors. A tumor is defined as the formation of solid mass tissue due to the abnormal growth of cells. MOOSTIN 40MG TABLET is used in the treatment of primary and metastatic brain tumors along with appropriate surgical or radiotherapeutic procedures. A brain tumor is a serious condition where the cells (cancerous or non-cancerous) grow abnormally in the brain. MOOSTIN 40MG TABLET is also used in the treatment of Hodgkin’s Disease when used in combination with other chemotherapies.
MOOSTIN 40MG TABLET contains Lomustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
MOOSTIN 40MG TABLET may cause certain side effects, such as nausea, vomiting, headache, visual disturbances, blindness, disorientation, lack of energy, loss of control, and difficulty talking. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. MOOSTIN 40MG TABLET should be taken as prescribed by your doctor. Do not take more than the recommended dose of medicine.
MOOSTIN 40MG TABLET should be avoided if you are allergic to it or any other components present in it. MOOSTIN 40MG TABLET may cause pulmonary toxicity, delayed myelosuppression, pulmonary fibrosis, nephrotoxicity, and hepatotoxicity in some patients. Hence, careful monitoring should be done during the entire treatment. This medicine is known to cause embryo-fetal harm in pregnant women. Hence, inform your doctor if you are pregnant or are planning to become pregnant. It is unknown whether MOOSTIN 40MG TABLET is suitable for children's use. Hence, please consult your doctor or paediatrician for information on children's use. Breastfeeding should be discontinued in nursing mothers during the treatment. MOOSTIN 40MG TABLET should only be taken once in 6 weeks as taking more than the recommended dose can cause serious life-threatening problems. Hence, talk to your doctor or pharmacist before starting the treatment.
MOOSTIN 40MG TABLET contains Lomustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
MOOSTIN 40MG TABLET should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. This medicine can cause a severe decrease in the number of blood cells in your bone marrow. A decrease in the number of blood cells in your body may cause certain symptoms and increase the risk of developing a serious infection or bleeding. Before administration, inform your doctor if you have liver/kidney disease, blood disorders, or respiratory conditions. MOOSTIN 40MG TABLET may cause pulmonary toxicity, delayed myelosuppression, pulmonary fibrosis, secondary malignancies, nephrotoxicity, and hepatotoxicity in some patients. Hence, careful monitoring should be done during the entire treatment. MOOSTIN 40MG TABLET is known to cause embryo-fetal harm in pregnant women. Hence, inform your doctor if you are pregnant or are planning to become pregnant. Breastfeeding should be discontinued in nursing mothers during the treatment. MOOSTIN 40MG TABLET should be given in children only if prescribed by the paediatrician. Avoid alcohol consumption and smoking, as it can lead to serious adverse effects. MOOSTIN 40MG TABLET may cause visual disturbances as a side effect. Hence, avoid driving vehicles or operating machines until you can see clearly. MOOSTIN 40MG TABLET should be taken once in 6 weeks only. Hence, talk to your doctor or pharmacist before starting the treatment.
Drug-Drug Interactions: MOOSTIN 40MG TABLET may interact with live vaccines, monoclonal antibodies (certolizumab, baricitinib, adalimumab ), antifungal drugs (ketoconazole), antipsychotic drug (clozapine), antirheumatic drug (leflunomide), etc.
Drug-Food Interactions: Avoid alcohol consumption and smoking.
Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease and pulmonary disorders before taking MOOSTIN 40MG TABLET.
Brain Tumors: A tumor is defined as the formation of solid mass tissue due to the abnormal growth of cells. A brain tumor is a serious condition where the cells (cancerous or non-cancerous) grow abnormally in the brain. There are different types of brain tumors which can be either benign (non-cancerous) or malignant (cancerous). MOOSTIN 40MG TABLET is used in the treatment of primary (a tumor that starts in any part of the brain) and metastatic (cancer cells which spread to other organs of the body) brain tumors.
Hodgkin’s Disease: Hodgkin’s disease or lymphoma is a blood cancer of a certain type of cells called WBCs, specifically lymphocytes. Lymphocytes normally help control infection and maintain the body's normal immunity. However, in a cancerous state, there is an abnormal multiplication of these blood cells, causing many problems such as fatigue, fever, loss of appetite, itching, night sweats and lymph node swelling.
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with MOOSTIN 40MG TABLET to prevent serious adverse effects.
Pregnancy
Unsafe
MOOSTIN 40MG TABLET is not recommended for use in pregnancy as it may harm your fetus. If you are pregnant or planning pregnancy, inform your doctor before taking MOOSTIN 40MG TABLET.
Breast Feeding
Unsafe
Avoid breastfeeding your child while on treatment with MOOSTIN 40MG TABLET as it causes serious side effects to the baby.
Driving
Unsafe
MOOSTIN 40MG TABLET may cause visual disturbances as a side effect. Avoid driving vehicles or operating machines until you are alert.
Liver
Caution
MOOSTIN 40MG TABLET may cause hepatotoxicity. If you have a pre-existing or a history of liver disease, inform your doctor before taking MOOSTIN 40MG TABLET. Your liver function should be monitored carefully before, during and after the treatment with MOOSTIN 40MG TABLET.
Kidney
Caution
MOOSTIN 40MG TABLET and its metabolites are known to be largely eliminated via the kidney, and the risk of adverse responses to this medicine may be higher in patients with impaired renal function. It may cause nephrotoxicity with progressive renal failure and a decrease in kidney size. Hence, if you have a pre-existing or a history of kidney disease, inform your doctor before taking MOOSTIN 40MG TABLET.
Children
Caution
Please consult a doctor. Your child's doctor may recommend this medicine based on the age, body weight and disease condition of your child.
Country of origin
Manufacturer/Marketer address
Product Substitutes